News und Analysen
DGAP-News: Dermapharm Holding SE übernimmt Allergopharma
DGAP-News: Dermapharm Holding SE to acquire Allergopharma
DGAP-Adhoc: Dermapharm Holding SE: Acquisition of Allergopharma
DGAP-Adhoc: Dermapharm Holding SE: Übernahme von Allergopharma
DGAP-News: Dermapharm Holding SE nimmt neues Logistikzentrum in Brehna in Betrieb
DGAP-News: Dermapharm Holding SE opens new logistics center in Brehna
DGAP-News: Dermapharm Holding SE treibt Unternehmenswachstum im dritten Quartal 2019 weiter voran
DGAP-News: Dermapharm Holding SE continues to drive the company's growth in the third quarter of 2019
Lindblad Expeditions (LIND) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q2 2024 Earnings CallAug 08, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Lindblad Expeditions (LIND) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q1 2024 Earnings CallApr 30, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Lindblad Expeditions (LIND) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q4 2023 Earnings CallFeb 28, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Lindblad Expeditions (LIND) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q3 2023 Earnings CallNov 02, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Down 22% in the Last Month, Why Lindblad Expeditions Stock Is a Buy
Adventure travel company Lindblad Expeditions (NASDAQ: LIND) has recently benefited from surging vacation demand. After sinking to an all-time low of $3.01 at the onset of the pandemic, its stock
Lindblad Expeditions (LIND) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q2 2023 Earnings CallJul 27, 2023, 8:30 a.m. ET
Operator
Source Fool.com
3 Reasons to Be Bullish on Lindblad Expeditions Stock
Expedition travel company Lindblad Expeditions (NASDAQ: LIND) has benefited from a recent wave of adventure tourism, now offering additional land-based adventures to complement its ever-evolving
Lindblad Expeditions Hits All-Time Highs in Revenue and Earnings. Time to Buy the Stock?
First-quarter earnings for Lindblad Expeditions (NASDAQ: LIND) landed all-time highs in both revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA). While resurgent
Lindblad Expeditions (LIND) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q1 2023 Earnings CallMay 03, 2023, 8:30 a.m. ET
Operator
Source Fool.com
EQS-News: Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies
EQS-News: Sustained organic growth in high-margin existing branded pharmaceutical business
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall